You can walk online right now, answer a few quick questions, and walk away with a prescription for medicinal cannabis containing up to eighty-eight percent THC. It sounds like a recreational dispensary model. But it is happening through official medical channels across Australia.
Recent investigations and research out of Monash University show a startling reality. Doctors are routinely prescribing high-dose medicinal cannabis products containing up to four times the concentration of THC tested in rigorous clinical trials. Out of more than a thousand available products, only two have ever undergone pre-market evaluation by the Therapeutic Goods Administration for quality, safety, and efficacy.
The system has a massive loophole. And commercial interests are cashing in.
The Evidence Gap Nobody Talks About
Let us look at what the science actually says. When researchers review randomized controlled trials, they find that clinical evidence usually maxes out at products containing around twenty-two percent THC. Yet, category five products ranging from thirteen to nearly ninety percent THC are being handed out like mints.
Why does this mismatch exist? Because there is no upper limit for THC concentration allowed in medicinal cannabis products in Australia.
Dr. Michael Wright, president of the Royal Australian College of General Practitioners, points out a glaring truth. There is basically no clinical need for THC concentrations to sit that high.
- Most clinical trials test products at much lower potencies.
- High-dose extracts and dried herbs carry heightened risks.
- Patients often bypass their regular GPs for single-purpose telehealth mills.
When you hand someone a product that is four times stronger than anything tested in a lab, you are running an open-air human experiment. And the results are starting to show up in hospital emergency wards.
What Happens When Potency Goes Too Far?
Delta-9-tetrahydrocannabinol is the main psychoactive component of cannabis. When you ramp up the dosage, you do not just get extra relief. You get extra risk.
Doctors are dealing with an alarming rise in patients presenting to emergency departments with cannabis-induced psychosis, severe anxiety, and dependency issues. If you have pre-existing mental health vulnerabilities, pumping massive amounts of THC into your system can trigger terrifying psychiatric episodes.
Yet, online cannabis clinics often operate as frictionless commercial entities. They rely on quick turnaround times. They utilize automated questionnaires that basically coach patients to say whatever is needed to secure a script.
It is fast. It is convenient. And it prioritizes the bottom line of commercial enterprises over the long-term well-being of the patient.
Fixing a Broken Prescribing Model
If you are considering medicinal cannabis, you need to know how proper care looks. Real medicine requires continuity. It requires a doctor who knows your full medical, mental health, and substance use history.
Here is what needs to change in how these treatments are managed:
- Demand real clinical oversight. Your regular general practitioner should be managing your care, not an anonymous telehealth service pushing a single product line.
- Question the potency. If a provider immediately jumps to high-THC category products without trying milder, evidence-backed treatments first, walk away.
- Establish an exit strategy. Any responsible prescription should come with a clear plan for what happens if the medicine fails to help or causes adverse side effects.
The regulatory crackdown is already happening, with sales experiencing a sharp correction as watchdogs target high-volume prescribers.
Stop treating high-potency cannabis like a harmless wellness supplement. It is a powerful controlled substance. Treat it like one.
